Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
USD 15 /hr
Hire Dr. Sven D.
Belgium
USD 15 /hr

Scientist and medical advisor

Profile Summary
Subject Matter Expertise
Services
Writing Medical Writing, Technical Writing
Research Fact Checking, Secondary Data Collection
Work Experience

Vrije Universiteit Brussel

- Present

Phd researcher in medical sciences

VUB

November 2015 - April 2021

Education

Master in bioscience engineering

KULeuven

September 2013 - June 2015

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
Hui Wang, Heng Jiang, Cyril Corbet, SVEN LUK DE MEY, Kalun Law, Thierry Gevaert, Olivier Feron, Mark De Ridder(2019). Piperlongumine increases sensitivity of colorectal cancer cells to radiation . Cancer Letters. 450. p. 42--52. Elsevier Ireland Ltd
Hanne Locy, SVEN LUK DE MEY, Wout De Mey, Mark De Ridder, Kris Thielemans, Sarah Maenhout(2018). Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend . Frontiers in Immunology. 9. Frontiers Media S.A.
SVEN LUK DE MEY, Heng Jiang, Hui Wang, Benedikt Engels, Thierry Gevaert, Inès Dufait, Olivier Feron, Joeri Aerts, Valeri Verovski, Mark De Ridder(2018). Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer Radiotherapy and Oncology . Radiotherapy and Oncology. 127. (3). p. 361--369. Elsevier Ireland Ltd
Hanne Locy, SVEN LUK DE MEY, Wout De Mey, Mark De Ridder, Kris Thielemans, Sarah K Maenhout(2018). Immunomodulation of the Tumor Microenvironment . Frontiers in Immunology. 9. Frontiers Media S.A.
Hui Wang, Soumaya Bouzakoura, SVEN LUK DE MEY, Heng Jiang, Kalun Law, Inès Dufait, Cyril Corbet, Valeri Verovski, Thierry Gevaert, Olivier Feron, et al.(2017). Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species . Oncotarget. 8. (22). p. 35728--35742. Impact Journals
CONFERENCE POSTER
SVEN LUK DE MEY, Soumaya Bouzakoura, Hui Wang, Inès Dufait, Lun Law Ka, Heng Jiang, Joeri Aerts, Mark De Ridder(2019). Colorectal cancer is associated with a clear decline in circulating central memory T cells that extends beyond age-related immunosenescence . BACR meeting 2019, 1/02/19.
Inès Dufait, SVEN LUK DE MEY, Hui Wang, Soumaya Bouzakoura, Heng Jiang, D. Escors, Mark De Ridder, Karine Breckpot(2016). Granzyme B expression in myeloid-derived suppressor cells: a current unidentified mechanism? . Cell – VIB Symposia, Ghent, Belgium, 11/12/16.
Hui Wang, Soumaya Bouzakoura, Heng Jiang, Lun Law Ka, Inès Dufait, SVEN LUK DE MEY, Valeri N. Verovski, Dirk Van den Berge, Guy Storme, Mark De Ridder(2016). Auranofin radiosensitizes tumor cells through enhanced production of reactive oxygen species . Cell – VIB Symposia, Ghent, Belgium, 11/12/16.
Inès Dufait, SVEN LUK DE MEY, Hui Wang, Soumaya Bouzakoura, Heng Jiang, D. Escors, Mark De Ridder, Karine Breckpot(2016). Granzyme B expression in myeloid-derived suppressor cells: a current unidentified mechanism? . ISCaM: Metabolics Networks in Cancer, Brussels, Belgium, 26/10/16.
OTHER
SVEN LUK DE MEY, H. Wang, J. Heng, Inès Dufait, K. Law, C. Corbet, V. Verovski, Thierry Gevaert, O. Feron, Mark De Ridder(2018). Phenformin radiosensitizes hypoxic tumor cells through inhibition of mitochondrial complex . Radiotherapy and Oncology. 127. p. S1275--S1275. Elsevier Ireland Ltd
CONFERENCE PAPER
Hui Wang, Heng Jiang, SVEN LUK DE MEY, Lun Law Ka, Valeri Verovski, Thierry Gevaert, Dirk Van Den Berge, Mark De Ridder(2017). Piperlongumine radiosensitizes hypoxic colorectal cancer cells through overproduction of reactive oxygen species . International conference on immunotherapy radiotherapy combinations, New York, 21/09/17.